Novolin Ge Toronto 100 Unit

Novolin GE Toronto 100 Unit is a human biosynthetic insulin injection designed for diabetes management. This 100 unit solution is manufactured by Novo Nordisk Canada Inc. and is suitable for intramuscular administration.

Novolin GE Toronto 100 Unit is primarily used for the management of diabetes. It helps regulate blood sugar levels in individuals who require insulin therapy. This insulin injection is often prescribed to help control both type 1 and type 2 diabetes, supporting overall glucose management.

Common effects of Novolin GE Toronto 100 Unit may include localized reactions at the injection site, such as redness or swelling. Some users might experience hypoglycemia if blood sugar levels drop too low. It is important to monitor blood sugar levels regularly while using this insulin injection.

Handle Novolin GE Toronto 100 Unit with care, ensuring it is stored properly to maintain its effectiveness. Always follow the guidance of a healthcare professional regarding administration and monitoring. Be aware of the signs of hypoglycemia and have a plan in place to manage it.

Novolin GE Toronto 100 Unit may interact with certain medications, including oral hypoglycemic agents and other drugs that affect blood sugar levels. Alcohol consumption can also impact the effectiveness of this insulin injection. Always consult a healthcare professional before combining it with other treatments.